Latest news

Thumbnail image for NHS Long Term Plan to save up to 500,000 lives

NHS Long Term Plan to save up to 500,000 lives

Long-awaited details of the NHS Long Term Plan, which is to be funded by a government investment of £20.5 billion a year in real terms by 2023/24 - have now been unveiled, with the promise of saving almost half a million more lives.

7th January 2019

Thumbnail image for Janssen files Stelara in Europe for ulcerative colitis

Janssen files Stelara in Europe for ulcerative colitis

Janssen has submitted an application to the European Medicines Agency (EMA) seeking to expand the approval of Stelara to include the treatment of adults with moderately to severely active ulcerative colitis (UC).

7th January 2019

Thumbnail image for Green light for Amryt's epidermolysis bullosa study

Green light for Amryt's epidermolysis bullosa study

An Independent Data Monitoring Committee (IDCM) has recommended that Amryt’s pivotal Phase III EASE trial for AP101 - a potential treatment for Epidermolysis Bullosa (EB) - should continue, raising hopes for a new therapy for the condition.

7th January 2019

Thumbnail image for UK surge in cell and gene therapy trials

UK surge in cell and gene therapy trials

A surge in cell and gene therapy trials - an increase of 37% since 2017 - highlights the UK’s leading position as a developmental hub in the sector, says the Cell and Gene Therapy Catapult.

7th January 2019

Thumbnail image for Bristol-Myers Squibb to buy Celgene

Bristol-Myers Squibb to buy Celgene

Bristol-Myers Squibb has unveiled its intent to acquire Celgene in a deal worth $74 billion, in order to “create a premier innovative biopharma company”.

7th January 2019

Thumbnail image for MHRA responds to consultation on Brexit no-deal proposals

MHRA responds to consultation on Brexit no-deal proposals

In advance of the UK leaving the European Union on 29 March 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) has released a statement detailing its preparations for the event of a no-deal Brexit scenario.

4th January 2019

Thumbnail image for Sprycel combo gets FDA approval

Sprycel combo gets FDA approval

The US Food and Drug Administration has approved the new treatment Sprycel for children one year of age and older, facing a type of blood cancer known as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) when used in combination with chemotherapy.

3rd January 2019

Thumbnail image for Exonate fundraises £1.5 million

Exonate fundraises £1.5 million

Exonate has successfully fundraised £1.5 million to accelerate development of its lead product - an eye drop treatment for retinal neovascular diseases.

3rd January 2019

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download